Importance of decision support implementation in emergency Department Vancomycin dosing

Western Journal of Emergency Medicine

Volumn 16, Issue 4, 2015, Pages 557-564

  Faine, Brett ^a   Mohr, Nicholas ^a   Harland, Kari K ^a   Rolfes, Kathryn ^b   Porter, Blake ^b   Fuller, Brian M ^c  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGE; APACHE; ARTICLE; BODY WEIGHT; COHORT ANALYSIS; COMPUTERIZED PROVIDER ORDER ENTRY; CRITICALLY ILL PATIENT; DECISION SUPPORT SYSTEM; DOSE CALCULATION; ELECTRONIC MEDICAL RECORD; EMERGENCY WARD; FEMALE; HOSPITAL MORTALITY; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MIDDLE AGED; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; AGED; CLINICAL DECISION SUPPORT SYSTEM; CRITICAL ILLNESS; ELECTRONIC HEALTH RECORD; HOSPITAL EMERGENCY SERVICE; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; MEDICATION ERROR; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIVARIATE ANALYSIS; ORGANIZATION AND MANAGEMENT; STAPHYLOCOCCAL INFECTIONS; STATISTICAL MODEL;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CRITICAL ILLNESS; DECISION SUPPORT SYSTEMS, CLINICAL; ELECTRONIC HEALTH RECORDS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; LOGISTIC MODELS; MALE; MEDICATION ERRORS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN;

EID: 84982106576     PISSN: 1936900X     EISSN: 19369018     Source Type: Journal    
DOI: 10.5811/westjem.2015.4.25760     Document Type: Article

References (24)

1. Rybak M, Lomaestro B, Rotschafer J.C., et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009; 66:82-98.
2. Sakoulas G, Moellering RC, Jr. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains. Clin Infect Dis. 2008; 46Suppl5:S360-7.
3. van Hal S.J., Fowler VG, Jr. Is it time to replace vancomycin in the treatment of methicillin-resistant Staphylococcus aureus infections? Clin Infect Dis. 2013; 56:1779-88.
4. Sakoulas G, Eliopoulos GM, Moellering R.C., Jr., et al. Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance? J Infect Dis. 2003; 187:929-38.
5. Sakoulas G, Eliopoulos GM, Fowler V.G., Jr., et al. Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function. Antimicrob Agents Chemother. 2005; 49:2687-92.
6. Wright SW, Wrenn KD Appropriateness of vancomycin use in the emergency department. Ann Emerg Med. 1998; 32:531-6.
7. Fuller BM, Mohr N, Skrupky L., et al. Emergency Department vancomycin use: dosing practices and associated outcomes. J Emerg Med. 2013; 44:910-8.
8. Hamilton LA, Christopher Wood G, Magnotti LJ, et al Treatment of methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia with high-dose vancomycin or linezolid. J Trauma Acute Care Surg. 2012; 72:1478-83.
9. Rivers E, Nguyen B, Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001; 345:1368-77.
10. May L, Cosgrove S, L'Archeveque M, et al. A call to action for antimicrobial stewardship in the emergency department: approaches and strategies. Ann Emerg Med. 2013; 62:69-77.e2.
11. Rosini JM, Grovola MR, Levine B.J., et al. Prescribing habits of vancomycin in the Emergency Department: are we dosing appropriately? J Emerg Med. 2013; 44:979-84.
12. Kumar A, Roberts D, Wood K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006; 34:1589-96.
13. Szczesiul JM, Fairbanks RJ, Hildebrand J.M., et al. Survey of physicians regarding clinical pharmacy services in academic emergency departments. Am J Health Syst Pharm. 2009; 66:576-9.
14. Liu C, Bayer A, Cosgrove S.E., et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011; 52:285-92.
15. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000; 894: i-xii, 1-253.
16. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int. 2012; 2:1-138.
17. von Elm E., Altman DG, Egger M, et al The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008; 61:344-9.
18. van Hal S.J., Paterson DL, Lodise TP Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter. Antimicrob Agents Chemother. 2013; 57:734-44.
19. Howden BP, Ward PB, Charles P.G., et al. Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis. 2004; 38:521-8.
20. Jeffres MN, Isakow W, Doherty J.A., et al. Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices. Chest. 2006; 130:947-55.
21. Teich JM, Merchia PR, Schmiz J.L., et al. Effects of computerized physician order entry on prescribing practices. Arch Intern Med. 2000; 160:2741-7.
22. David MZ, Medvedev S, Hohmann S.F., et al. Increasing burden of methicillin-resistant Staphylococcus aureus hospitalizations at US academic medical centers, 2003-2008. Infect Control Hosp Emidemiol. 2012; 33:782-9.
23. Grace E. Altered vancomycin pharmacokinetics in obese and morbidly obese patients: what we have learned over the past 30 years. J Antimicrob Chemother. 2012; 67:1305-10.
24. Reynolds DC, Waite LH, Alexander D.P., et al. Performance of a vancomycin dosage regimen developed for obese patients. Am J Health Syst Pharm. 2012; 69:944-50.